Condition 1: Opioid Induced Anxiety Disorder. Condition 2: Opioid Induced Depressive Disorder. Opioid abuse with other opioid-induced disorder Opioid abuse with opioid-induced mood disorder
Conditions
Interventions
Intervention 1: Intervention group: the multivitamin pill used in the considered intervention belongs to Osveh pharmaceutical corporation and includes (vitB12 6 mcg, vit B1 1.5 mg, vit B2 1.7 mg, vit
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male Age 18 or above Are under methadone medication as part of an overall treatment against drug abuse Have been referred to the opioid addiction treatment centre at urmia's razi hospital
Exclusion criteria
Exclusion criteria: Patients with stress and mood disorders that are being treated with antidepressant medication. Patients who have high score in beck‘s depression inventory and beck‘sAnxiety inventory test will be refered to a psychiatrist and will be removed from the study when they start taking antidepression ans anti stress medication. The pre-existence of uncontrolled metabolic disease . The simultaneus consumption of any food supplement. Having coeliac disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of depression in Beck's depression inventory. Timepoint: Before intervention and 12 weeks after intervention( end of intervention). Method of measurement: Beck‘s Depression Inventory.;Score of Anxiety in Beck's anxiety inventory. Timepoint: Before intervention and 12 weeks after intervention( end of intervention). Method of measurement: Beck‘s Anxiety Inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasim Talebiazar
Oroumia University of Medical Sciences
Outcome results
None listed